Tokyo, Japan

Susumu Takeuchi

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Hino, JP (2007 - 2017)
  • Tokyo, JP (2000 - 2018)

Company Filing History:


Years Active: 2000-2018

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Susumu Takeuchi: A Tokyo-based Innovator Revolutionizing the Pharmaceutical Industry

Introduction:

The world of pharmaceuticals owes much to brilliant minds like Susumu Takeuchi. Hailing from Tokyo, Japan, Takeuchi has made significant contributions to the field through his innovative inventions and valuable patents. With a remarkable portfolio of 10 patents, he has proven himself as a visionary in the development of cutting-edge compounds with pharmacological applications. In this article, we will delve into Takeuchi's latest patents, career highlights, collaborations, and his overall impact as a pioneering inventor.

Latest Patents:

One of Takeuchi's recent patents, titled "Pyrido[3,4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof," focuses on the development of a compound that demonstrates exceptional CDK4/6 inhibiting activity. This invention has the potential to significantly contribute to the treatment of various diseases, particularly those related to cell cycle dysregulation.

Another notable patent from Takeuchi is his work on "Pyrazine derivatives." This invention presents a novel pyrazine derivative or a pharmaceutically acceptable salt thereof, which shows promise in treating or preventing diseases associated with URAT1 involvement. Conditions like gout, hyperuricemia, hypertension, renal diseases, diabetes, and arteriosclerosis could potentially benefit from the therapeutic applications of this compound.

Career Highlights:

Susumu Takeuchi's illustrious career boasts collaborations with renowned pharmaceutical companies such as Teijin Pharma Limited and Teijin Limited. Teijin Pharma Limited specializes in the research and development of innovative healthcare solutions, while Teijin Limited is a conglomerate dedicated to various industries including pharmaceuticals, fibers, films, and more. Takeuchi's contributions within these organizations have played a crucial role in advancing their pharmaceutical portfolios, ultimately benefitting patients worldwide.

Collaborations:

Throughout his career, Takeuchi has collaborated with notable colleagues, further amplifying his impact. Two of his noteworthy coworkers are Yoshiyuki Matsumoto and Naoki Hase. Their collective expertise and synergy with Takeuchi have fostered a collaborative environment conducive to groundbreaking innovations in the pharmaceutical field.

Conclusion:

Susumu Takeuchi, the Tokyo-based innovator, has showcased his inventiveness through numerous patents focused on revolutionizing the pharmaceutical industry. His contributions in developing compounds with CDK4/6 inhibiting activity and pyrazine derivatives for various medical conditions have the potential to transform the lives of patients worldwide. Takeuchi's collaborations with prominent pharmaceutical companies and talented colleagues further solidify his position as a trailblazer in the field. In the years to come, we eagerly anticipate the next chapter of his extraordinary career, as he continues to leave a lasting impact on the world of healthcare and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…